Chrissy Morgenthaler

Chrissy Morgenthaler, MS, MBA, is an accomplished professional in clinical operations and development, currently serving as Sr. Director and Head of Development Operations at Revagenix, Inc. since April 2025. Previously, Chrissy held the position of Senior Director of Clinical Operations at Vir Biotechnology, Inc., overseeing operational programs for various infectious diseases. With extensive experience, including leadership roles at InCarda Therapeutics and Gilead Sciences, Chrissy has managed global studies, authored clinical study documents, and facilitated vendor oversight. Chrissy's educational background includes a Master of Science in Biotechnology from The Johns Hopkins University, an Executive MBA from the Quantic School of Business and Technology, and a B.S. in Geology from San José State University.